Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

157
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
157
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

363
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
363
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

305
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
305
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

279
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
279
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

163
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
163

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders.

The American journal of psychiatry·2023
Same author

Conceptualizing participation in the community mental health context: Beginning with the Clubhouse model.

International journal of qualitative studies on health and well-being·2021
Same author

Threat, hostility and violence in childhood and later psychotic disorder: population-based case-control study.

The British journal of psychiatry : the journal of mental science·2020
Same author

A comparison between self-report and interviewer-rated retrospective reports of childhood abuse among individuals with first-episode psychosis and population-based controls.

Journal of psychiatric research·2020
Same author

Threatening Life Events and Difficulties and Psychotic Disorder.

Schizophrenia bulletin·2020
Same author

Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression.

JAMA psychiatry·2018

Related Experiment Video

Updated: Jun 18, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

13.6K

Mirogabalin: a novel gabapentinoid or another false dawn?

Thomas J Craig1, Paul Farquhar-Smith

  • 1Department of Anaesthesia and Pain Medicine, The Royal Marsden Hospital, London, UK.

Current Opinion in Supportive and Palliative Care
|August 1, 2024
PubMed
Summary

Mirogabalin, a novel gabapentinoid, shows theoretical promise for neuropathic pain due to its targeted action. However, clinical evidence is mixed, with further large studies needed to confirm its benefits over traditional gabapentinoids.

More Related Videos

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
06:53

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

12.7K
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.0K

Related Experiment Videos

Last Updated: Jun 18, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

13.6K
A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
06:53

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

12.7K
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.0K

Area of Science:

  • Pharmacology
  • Neurology
  • Pain Management

Background:

  • Neuropathic pain is a significant clinical challenge.
  • Gabapentinoids are commonly prescribed for neuropathic pain.
  • Mirogabalin is a novel gabapentinoid with potential advantages.

Purpose of the Study:

  • To review current evidence on mirogabalin for neuropathic pain.
  • To compare mirogabalin with traditional gabapentinoids.
  • To assess mirogabalin's efficacy and safety profile.

Main Methods:

  • Review of existing clinical studies and evidence.
  • Analysis of mirogabalin's mechanism of action.
  • Comparison of adverse drug reactions and efficacy data.

Main Results:

  • Mirogabalin targets the α2δ-1 subunit of voltage-gated calcium channels, potentially reducing side effects.
  • Evidence suggests mirogabalin may be superior to placebo for some neuropathic pain syndromes.
  • Clinical data comparing mirogabalin to traditional gabapentinoids show mixed results regarding efficacy and side effect profiles.

Conclusions:

  • Mirogabalin presents theoretical advantages over traditional gabapentinoids.
  • Current clinical evidence is inconclusive regarding mirogabalin's superiority.
  • Larger, independent studies are necessary to fully evaluate mirogabalin's performance.